Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/79293
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability
Author: Harvey, B.
Nicotra, L.
Vu, M.
Smid, S.
Citation: Cytokine (Online), 2013; 63(2):209-217
Publisher: Academic Press
Issue Date: 2013
ISSN: 1096-0023
1043-4666
Statement of
Responsibility: 
B.S. Harvey, L.L. Nicotra, M. Vu, S.D. Smid
Abstract: Cannabinoid receptor activation is protective in animal colitis models. We sought to investigate if cannabinoids attenuated colitis-like tissue damage in human colonic specimens, with the hypothesis that cannabinoids would be protective in a cytokine-driven model of human colonic mucosal damage. Healthy human colonic mucosa was incubated with pro-inflammatory cytokines TNF-α and IL-1β to elicit colitis-like tissue damage. The cytokine-driven increase in scored crypt and mucosal damage and lymphocyte density was attenuated with concomitant hydrocortisone pretreatment. The cannabinoid receptor 2 (CB2) receptor-selective agonist JWH-015 significantly reduced colitis scores following cytokine incubation, as evidenced by a reduction in mucosal crypt and luminal epithelial damage and lymphocyte density in the lamina propria. The effect of JWH-015 was reversed in the presence of the CB2 receptor inverse agonist JTE-907. Anandamide was also protective in the cytokine-incubated explant colitis model in a manner reversible with JTE-907, while CB1 receptor agonism with ACEA was without effect. TNF-α and IL-1β together evoked an increase in paracellular epithelial permeability in Caco-2 cell monolayers over 48h of incubation. However, neither CB2 nor CB1 receptor activation altered the cytokine-evoked increase in permeability. These findings support a discrete role for CB2 receptors in the attenuation of detrimental pro-inflammatory cytokine-mediated mucosal damage in the human colon without directly affecting mucosal epithelial barrier function.
Keywords: Anandamide; Cannabinoid; Colitis; Epithelial permeability; Mucosal
Rights: Crown copyright © 2013
RMID: 0020130333
DOI: 10.1016/j.cyto.2013.04.032
Appears in Collections:Pharmacology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.